# US 2021/0079356 A1 · Complex Human Gut Microbiome Cultured In An Anaerobic Human Gut-On-A-Chip

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2021/0079356 A1
- Document ID: US20210079356A1
- Status: Published application
- Kind: A1
- Application number: 15/733,716
- Filed: 2019-04-02
- Published: 2021-03-18
- Earliest claimed: 2018-04-02
- Assignees: President and Fellows of Harvard College
- Applicants: President and Fellows of Harvard College
- Inventors: Richard Novak; Sasan Jalili-Firoozinezhad; Francesca S. Gazzaniga; Elizabeth L. Calamari; Diogo M. Camacho; Bret A. Nestor; Cicely Fadel; Michael L. Cronce; Dennis L. Kasper; Donald E. Ingber; Amir Bein
- Web page: https://patentgrep.com/patent/US20210079356A1

## CPC

- C12N 5/0679: {Cells of the gastro-intestinal tract}
- G01N 33/5082: {Supracellular entities, e.g. tissue, organisms}
- C12M 21/08: {for producing artificial tissue or for ex-vivo cultivation of tissue (prostheses A61F2/00, grafts A61L27/00)}
- C12M 23/16: {Microfluidic devices; Capillary tubes (integrated microfluidic structures B01L3/5027; microreactors B01J19/0093)}
- C12M 25/02: {Membranes; Filters (filters or filtration in general B01D24/00-B01D41/00)}
- C12M 29/04: {Filters; Permeable or porous membranes or plates, e.g. dialysis}
- C12N 1/20: Bacteria; Culture media therefor
- C12Q 1/02: involving viable microorganisms
- C12Q 1/10: Enterobacteria
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)
- C12M: APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; {APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS}
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES

## Abstract

A microfluidic device is directed to sustaining a complex microbial community in direct and indirect contact with living human intestinal cells in vitro. The device includes a first microchannel having cultured cells of a human intestinal epithelium and microbiota, the first microchannel further having a first level of oxygen. The device further includes a second microchannel having cultured cells of a vascular endothelium, the second microchannel further having a second level of oxygen. The device also includes a membrane located at an interface region between the first microchannel and the second microchannel, the membrane being composed of an oxygen-permeable material or further having pores via which oxygen flows between the first microchannel and the second microchannel to form a physiologically-relevant oxygen gradient.

## Claims

### Claim at position 1

1-22. (canceled)

### Claim 23

A method for establishing a stable complex community of gut commensal microbes in vitro, the method comprising:
providing cultured cells of an intestinal epithelium and microbiota in an environment having a first level of oxygen, the microbiota being in direct and indirect contact with the intestinal epithelium;
providing cultured cells of endothelium in an environment having a second level of oxygen, the second level of oxygen having a greater oxygen concentration than the first level of oxygen; and
facilitating the flux of oxygen between the first level of oxygen and the second level of oxygen to form a physiologically-relevant oxygen gradient.

### Claim at position 3

24-25. (canceled)

### Claim 26 (depends on 23)

The method of claim 23, further comprising providing oxygenation of the cultured cells of the intestinal epithelium and the cultured cells of the vascular endothelium while simultaneously providing an anaerobic environment for growth of obligate anaerobes.

### Claim 27 (depends on 23)

The method of claim 23, further comprising achieving an oxygen concentration of less than approximately 0.5-2.0% in the first level of oxygen.

### Claim at position 6

28-30. (canceled)

### Claim 31

A microfluidic device having a first microchannel comprising a plurality of living parenchyma cells in direct contact with a plurality of living microbes, wherein the microbes are derived from a mammalian fecal sample.

### Claim 32 (depends on 31)

The microfluidic device of claim 31, wherein the parenchyma cells are selected from the group consisting of cells of the small intestine, ilea, duodenum, lung, alveolar, and skin.

### Claim 33 (depends on 31)

The microfluidic device of claim 31, wherein the mammal is a human.

### Claim 34 (depends on 31)

The microfluidic device of claim 31, further comprising a second microchannel.

### Claim 35 (depends on 34)

The microfluidic device of claim 34, wherein the first and second microchannels comprise media.

### Claim 36 (depends on 34)

The microfluidic device of claim 34, wherein the media in the second microchannel is oxygenated.

### Claim 37 (depends on 34)

The microfluidic device of claim 34, wherein the device has a gas gradient.

### Claim 38 (depends on 37)

The microfluidic device of claim 37, wherein the gas in the first microchannel is at a lower concentration than the gas in the second microchannel.

### Claim 39 (depends on 38)

The microfluidic device of claim 38, wherein the gas is selected from the group consisting of oxygen, nitrogen and carbon dioxide.

### Claim 40 (depends on 34)

The microfluidic device of claim 34, wherein the second microchannel comprises living endothelial cells.

### Claim 41 (depends on 31)

The microfluidic device of claim 31, wherein the plurality of microbes comprises both anaerobic bacteria and aerobic bacteria.

### Claim 42 (depends on 31)

The microfluidic device of claim 31, wherein the plurality of microbes comprises both Firmicutes phyla and Bacteroidetes phyla.

### Claim 43 (depends on 31)

The microfluidic device of claim 31, wherein the Firmicutes species are selected from the group consisting of Akkermansia, Oscillospira, Blautia and Suterella species.

### Claim 44 (depends on 31)

The microfluidic device of claim 31, wherein the plurality of microbes comprises Coprococcus, Anaerobacillus, Bifidobacterium, and Peptoniphilus species.

### Claim 45 (depends on 31)

The microfluidic device of claim 31, wherein the plurality of microbes comprises at least 8 different genera of bacteria found in human feces.

### Claim 46 (depends on 45)

The microfluidic device of claim 45, wherein the plurality of microbes comprises at least 11 different genera of bacteria found in human feces.

### Claim at position 23

47-54. (canceled)

### Claim 55 (depends on 23)

The method of claim 23, wherein the cultured microbiota are derived from a fecal sample.

### Claim 56 (depends on 55)

The method of claim 55, wherein the fecal sample was not passed through another mammal.

### Claim 57 (depends on 55)

The method of claim 55, wherein the fecal sample was not cultured in vitro.

### Claim 58 (depends on 55)

The method of claim 55, wherein the fecal sample comprises both anaerobic bacteria and aerobic bacteria.

### Claim at position 28

59-60. (canceled)

### Claim 61 (depends on 23)

The method of claim 23, wherein the cultured microbiota comprises organisms from both the Firmicutes phyla and the Bacteroidetes phyla.

### Claim 62 (depends on 23)

The method of claim 23, wherein the cultured microbiota comprises species selected from the group consisting of Akkermansia, Oscillospira, Blautia and Suterella species.

### Claim 63 (depends on 23)

The method of claim 23, wherein the cultured microbiota comprises Coprococcus, Anaerobacillus, Bifidobacterium, and Peptoniphilus species.

### Claim 64 (depends on 23)

The method of claim 23, wherein the cultured microbiome comprises at least 8 different genera of bacteria found in human feces.

### Claim 65 (depends on 23)

The method of claim 23, wherein the cultured microbiome comprises at least 11 different genera of bacteria found in human feces.

### Claim at position 34

66-89. (canceled)

### Claim 90

A method, comprising:
a) providing a microfluidic device and a portion of a mammalian fecal sample, the portion comprising living microbes;
b) introducing the portion into the microfluidic device; and
c) culturing the living microbes in the microfluidic device so as to create a cultured microbiome.

### Claim 91 (depends on 90)

The method of claim 90, wherein, prior to the introducing of step b) the portion of the fecal sample is suspended in a sterile solution so as to create a fecal slurry.

### Claim 92 (depends on 91)

The method of claim 91, wherein the suspending takes place inside an anaerobic chamber.

### Claim 93 (depends on 91)

The method of claim 91, wherein, after the suspending, the slurry is passed through a filter, so as to generate a microbiome stock derived directly from a fecal sample.

### Claim 94

(canceled)

### Claim 95 (depends on 93)

The method of claim 93, further comprising diluting the microbiome stock so as to create a diluted stock, the diluted stock being introduced in step b).

### Claim 96 (depends on 95)

The method of claim 95, wherein the diluting the microbiome stock generates a concentration of microbes of approximately 1×107 CFU ml-1.

### Claim 97 (depends on 90)

The method of claim 90, wherein the mammalian fecal sample is from a human.

### Claim 98 (depends on 97)

The method of claim 97, wherein the human is selected from the group consisting of a preterm infant, infant, child, teen, and an adult.

### Claim at position 44

99-102. (canceled)

### Claim 103 (depends on 97)

The method of claim 97, wherein the fecal sample of step a) was not passed through another mammal.

### Claim 104 (depends on 97)

The method of claim 97, wherein the fecal sample of step a) was not cultured in vitro.

### Claim 105 (depends on 90)

The method of claim 90, wherein the fecal sample comprises both anaerobic bacteria and aerobic bacteria.

### Claim 106 (depends on 105)

The method of claim 105, wherein the cultured microbiome comprises at least one of the same anaerobic bacteria types and aerobic bacteria types of the fecal sample.

### Claim 107 (depends on 90)

The method of claim 90, wherein the cultured microbiome comprises both Firmicutes phyla and Bacteroidetes phyla.

### Claim 108 (depends on 90)

The method of claim 90, wherein the cultured microbiome comprises species selected from the group consisting of Akkermansia, Oscillospira, Blautia and Suterella species.

### Claim 109 (depends on 90)

The method of claim 90, wherein the cultured microbiome comprises Coprococcus, Anaerobacillus, Bifidobacterium, and Peptoniphilus species.

### Claim 110 (depends on 90)

The method of claim 90, wherein the cultured microbiome comprises at least 8 different genera of bacteria found in human feces.

### Claim 111 (depends on 90)

The method of claim 90, wherein the cultured microbiome comprises at least 11 different genera of bacteria found in human feces.

### Claim at position 54

112-113. (canceled)

### Claim 114 (depends on 90)

The method of claim 90, wherein the microfluidic device comprises a first microchannel comprising a plurality of living parenchyma cells.

### Claim 115 (depends on 114)

The method of claim 114, wherein the introducing of step b) results in the parenchyma cells being in direct contact with a plurality of living microbes.

### Claim 116 (depends on 114)

The method of claim 114, wherein the parenchyma cells are selected from the group consisting of cells of the small intestine, ilea, duodenum, lung, alveolar, and skin.

### Claim 117 (depends on 116)

The method of claim 116, wherein the cells are intestinal epithelial cells.

### Claim 118 (depends on 114)

The method of claim 114, wherein the microfluidic device further comprises a second microchannel.

### Claim 119 (depends on 118)

The method of claim 118, wherein the first and second microchannels comprise media.

### Claim 120 (depends on 119)

The method of claim 119, wherein the media in the second microchannel is oxygenated.

### Claim 121 (depends on 118)

The method of claim 118, wherein the microfluidic device has a gas gradient.

### Claim 122 (depends on 121)

The method of claim 121, wherein the gas in the first microchannel is at a lower concentration than the gas in the second microchannel.

### Claim 123 (depends on 122)

The method of claim 122, wherein the gas is selected from the group consisting of oxygen, nitrogen and carbon dioxide.

### Claim 124 (depends on 118)

The method of claim 118, wherein the second microchannel comprises living endothelial cells.

### Claim 125 (depends on 121)

The method of claim 121, wherein the gas gradient provides anaerobic conditions in the first microchannel.

### Claim 126 (depends on 114)

The method of claim 114, wherein the introducing of step b) results in the parenchyma cells being in direct contact with living obligate anaerobes.

### Claim 127 (depends on 90)

The method of claim 90, wherein the culturing comprises flowing media at a flow rate.

### Claim 128 (depends on 118)

The method of claim 118, wherein the second microchannel is positioned below the first microchannel and separated from the first microchannel by a membrane.

### Claim 129 (depends on 128)

The method of claim 128, wherein oxygenated medium flows through the second microchannel from external oxygenated medium reservoirs.

### Claim 130 (depends on 129)

The method of claim 129, wherein parenchyma cells in the first microchannel get oxygen from the second microchannel.

### Claim 131

(canceled)

### Claim 132 (depends on 90)

The method of claim 90, wherein the culturing takes place for at least 3 days.

### Claim 133

(canceled)

### Claim 134 (depends on 132)

The method of claim 132, wherein cultured microbiome comprises both anaerobic bacteria and aerobic bacteria.

### Claim 135 (depends on 132)

The method of claim 132, wherein the cultured microbiome comprises at least 2 anaerobic species found in the fecal sample.

### Claim 136 (depends on 132)

The method of claim 132, wherein the cultured microbiome comprises microbes from at least 2 genera found in the fecal sample.

### Claim 137

A method, comprising:
a) providing a microfluidic device and living microbes from the surface or contents of a body, orifice or cavity;
b) introducing at least a portion of the living microbes into the microfluidic device; and
c) culturing the living microbes in the microfluidic device so as to create a cultured microbiome.

### Claim 138 (depends on 137)

The method of claim 137, where the surface of a body is skin.

### Claim 139 (depends on 137)

The method of claim 137, wherein the content of a body is saliva.

### Claim 140 (depends on 137)

The method of claim 137, wherein the body is the body of a mammal.

### Claim 141 (depends on 137)

The method of claim 137, wherein the body is the body of a non-mammal.

### Claim 142 (depends on 114)

The method of claim 114, wherein the non-mammal is a bird.

### Claim 143 (depends on 137)

The method of claim 137, wherein the culturing comprises flowing media at a flow rate.

### Claim at position 85

144-147. (canceled)

### Claim 148

A method, comprising:
a) providing a microfluidic device, a source of microbes comprising living obligate anaerobes and living parenchyma cells; and
b) culturing the obligate anaerobes and the parenchyma cells in the microfluidic device such that at least a portion of the obligate anaerobes and at least a portion of the parenchyma cells are in direct contact.

### Claim 149 (depends on 148)

The method of claim 148, wherein the living obligate anaerobes are from the surface or contents of a body, orifice or cavity.

### Claim 150 (depends on 148)

The method of claim 148, wherein the parenchyma cells are human intestinal epithelial cells.

### Claim 151 (depends on 148)

The method of claim 148, wherein, after the culturing, unknown microbes are identified.

### Claim 152 (depends on 148)

The method of claim 148, wherein the culturing comprises flowing media at a flow rate.

### Claim 153 (depends on 148)

The method of claim 148, wherein the microfluidic device comprises a second microchannel positioned below a first microchannel and separated from the first microchannel by a membrane.

### Claim at position 92

154-156. (canceled)

### Claim 157 (depends on 148)

The method of claim 148, wherein the culturing takes place for at least 3 days.

### Claim 158

(canceled)

### Claim 159 (depends on 157)

The method of claim 157, wherein cultured microbiome comprises both anaerobic bacteria and aerobic bacteria.

### Claim 160 (depends on 157)

The method of claim 157, wherein the cultured microbiome comprises at least 2 anaerobic species found in the fecal sample.

### Claim 161 (depends on 157)

The method of claim 157, wherein the cultured microbiome comprises microbes from at least 2 genera found in the fecal sample.

### Claim 162 (depends on 157)

The method of claim 157, wherein the cultured microbiome comprises ratios of Firmicutes and Bacteroidetes bacteria observed in human feces.

### Claim 163 (depends on 157)

The method of claim 157, wherein the cultured microbiome comprises Akkermansia muciniphila in greater abundance than in stool.

### Claim 164

A method, comprising:
a) providing i) a source of microbes comprising living obligate anaerobes and ii) a microfluidic device comprising intestinal epithelial cells which exhibit multi-lineage differentiation, villi formation, and mucus production; and
b) culturing the microbes and intestinal cells in the microfluidic device such that at least a portion of the microbes surround the villi.

### Claim 165 (depends on 164)

The method of claim 164, further comprising c) real time visualization of bacteria surrounding villi.

### Claim 166 (depends on 164)

The method of claim 164, wherein the cultured microbes represent 6 phyla.

### Claim 167 (depends on 166)

The method of claim 166, wherein said 6 phyla comprise Actinobacteria, Bacteroidetes, Cyanobacteria, Firmicutes, Proteobacteria and Tenericutes.
